Join us in decoding a new layer of pediatric cancer biology! Open since Oct 08, 2026
Introduction
Our FWF Emerging Fields Consortium brings together six complementary research groups ( Falk , Grebien , Hein , Karagöz , Seruggia , Tomazou ) across leading biomedical research institutions in Vienna to investigate the ribosome and translational control as a new and largely unexplored layer of pediatric cancer biology and therapy resistance. By combining cutting-edge genomic, proteomic, biochemical and structural approaches, we aim to decode cancer-specific mechanisms of translational regulation, the "ribosome code", and identify novel therapeutic vulnerabilities that could lead to safer and more effective treatments for children and adolescents with solid and hematological cancers. As a postdoctoral researcher, you will join one of the participating research groups
while being part of a multidisciplinary consortium bringing together complementary expertise in pediatric cancer, translational regulation, RNA biology, functional genomics, proteomics and structural biology. Candidates
Successful candidates should have a PhD in molecular biology, cancer biology, biochemistry, molecular medicine, genomics, bioinformatics, structural biology or a related field a strong scientific track record appropriate to your career stage research experience relevant to at least one of the participating groups a strong interest in interdisciplinary and collaborative research the ability to work independently while contributing effectively to a collaborative research environment excellent written and spoken English Contact
The application deadline
is 15.11.2026 .
